Anti-Inflammatory Thrombolytic JX10 (TMS-007) in Late Presentation of Acute Ischemic StrokeAuthorsKeiji Hasumi (ORCID: https://orcid.org/0000-0002-3340-7312)Yukio Umeda (ORCID: https://orcid.org/0000-0001-5549-0666)Kazuhiko Kuribayashi (ORCID: https://orcid.org/0000-0001-5253-8783)Michael Wald (ORCID: https://orcid.org/0000-0003-3349-7415)Kohsuke Kudo (ORCID: https://orcid.org/0000-0001-5351-9242)Yasuo TodaTakashi MoritoyoKuniyasu Niizuma (ORCID: https://orcid.org/0000-0001-9282-6499)Naoko NishimuraTeiji Tominaga (ORCID: https://orcid.org/0000-0003-3411-2900)Josh BellKeiko HasegawaInstitutionsKagoshima University (JP)Toshiba (Japan) (JP)Biogen (United States) (US)Hatch (Canada) (CA)Tokyo University of Technology (JP)Tohoku University (JP)Sapporo University (JP)Hokkaido University (JP)University of Tokyo Hospital (JP)Publication DetailsJournalStrokePublished2024-11-07DOIhttps://doi.org/10.1161/strokeaha.124.048464Citations6Primary TopicAtherosclerosis and Cardiovascular DiseasesTypearticleField-Weighted Citation Impact1.44FundersBiogenExplore the Global Research Space Interactive Map